Xinjia Ding, Xiaoyan Bai, Zhigao Wang, Xiaohui Li, Nanlin Hu, Shikai Wu. "Disitamab vedotin plus PD-1 inhibitors as neoadjuvant therapy for cisplatin-ineligible muscle-invasive bladder cancer: A real-world retrospective study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.691